SL

Simon Lord

Owner, Franchise New Zealand

Franchise New Zealand

s***@nature.com Upgrade
Pro only
Auckland, Auckland, New Zealand

Recent Article

Author Correction: Dose escalation and expansion cohorts in patients with advanced breast cancer in a Phase I study of the CDK7-inhibitor samuraciclib | Nature Communications

Upgrade for article links
45 total articles published